What does this research mean for the field?

Cancer cachexia in advanced renal cell carcinoma is driven by systemic inflammation and metabolic reprogramming, and its prognostic assessment and management require integrating biomarkers, imaging, and multimodal interventions. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To synthesize the biological mechanisms, prognostic assessment strategies, and therapeutic interventions for cancer cachexia in patients with advanced renal cell carcinoma.

September 8, 2026International Journal of Molecular SciencesOpen Access

Cancer Cachexia in Advanced Renal Cell Carcinoma: From Molecular Mechanisms to Prognostic Assessment

View Full Paper

Ask AI

Bookmark

Authors

YCYushuang Cui YCYudong Cao CLChen Lin

Discussion

Member takes

Overview

Review explores molecular pathways and prognostic biomarkers of cachexia in advanced renal cell carcinoma, highlighting personalized multimodal management strategies.

Key Points

To synthesize the biological mechanisms, prognostic assessment strategies, and therapeutic interventions for cancer cachexia in patients with advanced renal cell carcinoma.
Reviewed cellular and molecular pathways responsible for muscle catabolism, systemic inflammation, and metabolic reprogramming in renal cell carcinoma.
Evaluated the clinical utility of computed tomography body composition analysis combined with inflammatory and nutritional indices.
Examined current multimodal management paradigms, targeted pharmaceuticals, and emerging experimental therapies.
Cachexia occurs in 30% to 60% of patients with advanced renal cell carcinoma and is propagated by IL-6/STAT3, TNF-α/NF-κB, GDF15, PTHrP, and mitochondrial dysfunction.
Integrating computed tomography-measured skeletal muscle mass with inflammatory biomarkers—including NLR, mGPS, PNI, and CXI—enhances prognostic risk stratification.
Multimodal regimens combining nutritional support and exercise remain central to management, while novel targeted strategies like GDF15/GFRAL axis inhibition show therapeutic potential.

Cite This Study

Cui et al. (2026) studied this question.

synapsesocial.com/papers/6a9fd83b58e84d0ff5b47aca https://doi.org/10.3390/ijms27177944

View Full Paper

Ask AI

Bookmark

September 8, 2026International Journal of Molecular SciencesOpen Access

Cancer Cachexia in Advanced Renal Cell Carcinoma: From Molecular Mechanisms to Prognostic Assessment

View Full Paper

Ask AI

Bookmark

Authors

YCYushuang Cui YCYudong Cao CLChen Lin

Discussion

Member takes

Overview

Review explores molecular pathways and prognostic biomarkers of cachexia in advanced renal cell carcinoma, highlighting personalized multimodal management strategies.

Key Points

To synthesize the biological mechanisms, prognostic assessment strategies, and therapeutic interventions for cancer cachexia in patients with advanced renal cell carcinoma.
Reviewed cellular and molecular pathways responsible for muscle catabolism, systemic inflammation, and metabolic reprogramming in renal cell carcinoma.
Evaluated the clinical utility of computed tomography body composition analysis combined with inflammatory and nutritional indices.
Examined current multimodal management paradigms, targeted pharmaceuticals, and emerging experimental therapies.
Cachexia occurs in 30% to 60% of patients with advanced renal cell carcinoma and is propagated by IL-6/STAT3, TNF-α/NF-κB, GDF15, PTHrP, and mitochondrial dysfunction.
Integrating computed tomography-measured skeletal muscle mass with inflammatory biomarkers—including NLR, mGPS, PNI, and CXI—enhances prognostic risk stratification.
Multimodal regimens combining nutritional support and exercise remain central to management, while novel targeted strategies like GDF15/GFRAL axis inhibition show therapeutic potential.

Cite This Study

Cui et al. (2026) studied this question.

synapsesocial.com/papers/6a9fd83b58e84d0ff5b47aca https://doi.org/10.3390/ijms27177944

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark